This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter    Login            

England’s chief pharmacist appointed to probe ‘problematic’ overprescribing in NHS

The Government has chosen England’s chief pharmacist to look into “problematic” overprescribing in the NHS, it has announced.

Health and Social care secretary Matt Hancock revealed last week (8 December) that the Government will look into overprescribing to address “problematic polypharmacy” and ensure patients receive the treatment they need.

The review will be conducted by England’s chief pharmaceutical officer Dr Keith Ridge, the Government said.

The review will mainly focus on addressing “problematic polypharmacy”, where needed, and reducing overprescribing, the Government said.

Article continues below this sponsored advert
Cogora InRead Image
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE

Dr Ridge will be tasked with ensuring pharmacists and doctors receive the support they need to review prescriptions and provide patients with “the most appropriate treatment for their needs”, the Government said. 

He will look in particular at situations where there is a potential overlap of multiple medicines prescribed to treat the same condition and where people are subject to repeat prescriptions without being reviewed.

Mr Hancock said: “Recent advances in medicine have led to fantastic developments in managing and treating certain conditions, but poorly managed prescribing can lead to serious issues for patients such as increased admissions to hospital or antibiotic resistance.

“As we invest an extra £20.5bn a year into our NHS, we want to empower doctors and pharmacists to use the data available to ensure patients get the medicines they need and stop taking those that no longer benefit them.”

According to the Government, NHS spending on medicines has risen by 5% a year between 2010 and 2018, from £13bn to £18.2bn.